 | • レポートコード：MRC2012A5122 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、頭蓋内アテローム性動脈硬化症治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。頭蓋内アテローム性動脈硬化症治療の種類別市場規模（ステント、PTAバルーン）、用途別市場規模（病院、クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Stryker、MicroPort、Balt、TERUMO、Acandis ・地域別グローバル市場分析 2015年-2020年 ・頭蓋内アテローム性動脈硬化症治療の北米市場（アメリカ、カナダ、メキシコ） ・頭蓋内アテローム性動脈硬化症治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・頭蓋内アテローム性動脈硬化症治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・頭蓋内アテローム性動脈硬化症治療の南米市場（ブラジル、アルゼンチン） ・頭蓋内アテローム性動脈硬化症治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ステント、PTAバルーン ・用途別分析：病院、クリニック、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The Intracranial Atherosclerotic Disease Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Intracranial Atherosclerotic Disease Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
Market segmentation
Intracranial Atherosclerotic Disease Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Intracranial Atherosclerotic Disease Treatment market has been segmented into
Stent
PTA Balloon
By Application, Intracranial Atherosclerotic Disease Treatment has been segmented into:
Hospital
Clinic
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Intracranial Atherosclerotic Disease Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Intracranial Atherosclerotic Disease Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Intracranial Atherosclerotic Disease Treatment market.
The report offers in-depth assessment of the growth and other aspects of the Intracranial Atherosclerotic Disease Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Intracranial Atherosclerotic Disease Treatment Market Share Analysis
Intracranial Atherosclerotic Disease Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Intracranial Atherosclerotic Disease Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Intracranial Atherosclerotic Disease Treatment sales, revenue and market share for each player covered in this report.
The major players covered in Intracranial Atherosclerotic Disease Treatment are:
Stryker
MicroPort
Balt
TERUMO
Acandis
Among other players domestic and global, Intracranial Atherosclerotic Disease Treatment market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Intracranial Atherosclerotic Disease Treatment product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Intracranial Atherosclerotic Disease Treatment, with price, sales, revenue and global market share of Intracranial Atherosclerotic Disease Treatment in 2018 and 2019.
Chapter 3, the Intracranial Atherosclerotic Disease Treatment competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Intracranial Atherosclerotic Disease Treatment breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Intracranial Atherosclerotic Disease Treatment market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Intracranial Atherosclerotic Disease Treatment sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Intracranial Atherosclerotic Disease Treatment Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Intracranial Atherosclerotic Disease Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Stent
1.2.3 PTA Balloon
1.3 Market Analysis by Application
1.3.1 Overview: Global Intracranial Atherosclerotic Disease Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Overview of Global Intracranial Atherosclerotic Disease Treatment Market
1.4.1 Global Intracranial Atherosclerotic Disease Treatment Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Stryker
2.1.1 Stryker Details
2.1.2 Stryker Major Business
2.1.3 Stryker SWOT Analysis
2.1.4 Stryker Product and Services
2.1.5 Stryker Intracranial Atherosclerotic Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 MicroPort
2.2.1 MicroPort Details
2.2.2 MicroPort Major Business
2.2.3 MicroPort SWOT Analysis
2.2.4 MicroPort Product and Services
2.2.5 MicroPort Intracranial Atherosclerotic Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Balt
2.3.1 Balt Details
2.3.2 Balt Major Business
2.3.3 Balt SWOT Analysis
2.3.4 Balt Product and Services
2.3.5 Balt Intracranial Atherosclerotic Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 TERUMO
2.4.1 TERUMO Details
2.4.2 TERUMO Major Business
2.4.3 TERUMO SWOT Analysis
2.4.4 TERUMO Product and Services
2.4.5 TERUMO Intracranial Atherosclerotic Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Acandis
2.5.1 Acandis Details
2.5.2 Acandis Major Business
2.5.3 Acandis SWOT Analysis
2.5.4 Acandis Product and Services
2.5.5 Acandis Intracranial Atherosclerotic Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Intracranial Atherosclerotic Disease Treatment Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Intracranial Atherosclerotic Disease Treatment Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Intracranial Atherosclerotic Disease Treatment Manufacturer Market Share in 2019
3.3.2 Top 6 Intracranial Atherosclerotic Disease Treatment Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Intracranial Atherosclerotic Disease Treatment Sales, Revenue and Market Share by Regions
4.1.1 Global Intracranial Atherosclerotic Disease Treatment Sales and Market Share by Regions (2015-2020)
4.1.2 Global Intracranial Atherosclerotic Disease Treatment Revenue and Market Share by Regions (2015-2020)
4.2 North America Intracranial Atherosclerotic Disease Treatment Sales and Growth Rate (2015-2020)
4.3 Europe Intracranial Atherosclerotic Disease Treatment Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Intracranial Atherosclerotic Disease Treatment Sales and Growth Rate (2015-2020)
4.5 South America Intracranial Atherosclerotic Disease Treatment Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Intracranial Atherosclerotic Disease Treatment Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Intracranial Atherosclerotic Disease Treatment Sales, Revenue and Market Share by Country
5.1.1 North America Intracranial Atherosclerotic Disease Treatment Sales and Market Share by Country (2015-2020)
5.1.2 North America Intracranial Atherosclerotic Disease Treatment Revenue and Market Share by Country (2015-2020)
5.2 United States Intracranial Atherosclerotic Disease Treatment Sales and Growth Rate (2015-2020)
5.3 Canada Intracranial Atherosclerotic Disease Treatment Sales and Growth Rate (2015-2020)
5.4 Mexico Intracranial Atherosclerotic Disease Treatment Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Intracranial Atherosclerotic Disease Treatment Sales, Revenue and Market Share by Country
6.1.1 Europe Intracranial Atherosclerotic Disease Treatment Sales and Market Share by Country (2015-2020)
6.1.2 Europe Intracranial Atherosclerotic Disease Treatment Revenue and Market Share by Country (2015-2020)
6.2 Germany Intracranial Atherosclerotic Disease Treatment Sales and Growth Rate (2015-2020)
6.3 UK Intracranial Atherosclerotic Disease Treatment Sales and Growth Rate (2015-2020)
6.4 France Intracranial Atherosclerotic Disease Treatment Sales and Growth Rate (2015-2020)
6.5 Russia Intracranial Atherosclerotic Disease Treatment Sales and Growth Rate (2015-2020)
6.6 Italy Intracranial Atherosclerotic Disease Treatment Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Intracranial Atherosclerotic Disease Treatment Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Intracranial Atherosclerotic Disease Treatment Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Intracranial Atherosclerotic Disease Treatment Revenue and Market Share by Regions (2015-2020)
7.2 China Intracranial Atherosclerotic Disease Treatment Sales and Growth Rate (2015-2020)
7.3 Japan Intracranial Atherosclerotic Disease Treatment Sales and Growth Rate (2015-2020)
7.4 Korea Intracranial Atherosclerotic Disease Treatment Sales and Growth Rate (2015-2020)
7.5 India Intracranial Atherosclerotic Disease Treatment Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Intracranial Atherosclerotic Disease Treatment Sales and Growth Rate (2015-2020)
7.7 Australia Intracranial Atherosclerotic Disease Treatment Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Intracranial Atherosclerotic Disease Treatment Sales, Revenue and Market Share by Country
8.1.1 South America Intracranial Atherosclerotic Disease Treatment Sales and Market Share by Country (2015-2020)
8.1.2 South America Intracranial Atherosclerotic Disease Treatment Revenue and Market Share by Country (2015-2020)
8.2 Brazil Intracranial Atherosclerotic Disease Treatment Sales and Growth Rate (2015-2020)
8.3 Argentina Intracranial Atherosclerotic Disease Treatment Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Intracranial Atherosclerotic Disease Treatment Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Intracranial Atherosclerotic Disease Treatment Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Intracranial Atherosclerotic Disease Treatment Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Intracranial Atherosclerotic Disease Treatment Sales and Growth Rate (2015-2020)
9.3 Turkey Intracranial Atherosclerotic Disease Treatment Sales and Growth Rate (2015-2020)
9.4 Egypt Intracranial Atherosclerotic Disease Treatment Sales and Growth Rate (2015-2020)
9.5 South Africa Intracranial Atherosclerotic Disease Treatment Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Intracranial Atherosclerotic Disease Treatment Sales and Market Share by Type (2015-2020)
10.2 Global Intracranial Atherosclerotic Disease Treatment Revenue and Market Share by Type (2015-2020)
10.3 Global Intracranial Atherosclerotic Disease Treatment Price by Type (2015-2020)
11 Global Intracranial Atherosclerotic Disease Treatment Market Segment by Application
11.1 Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Application (2015-2020)
11.2 Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Application (2015-2020)
11.3 Global Intracranial Atherosclerotic Disease Treatment Price by Application (2015-2020)
12 Market Forecast
12.1 Global Intracranial Atherosclerotic Disease Treatment Sales, Revenue and Growth Rate (2021-2025)
12.2 Intracranial Atherosclerotic Disease Treatment Market Forecast by Regions (2021-2025)
12.2.1 North America Intracranial Atherosclerotic Disease Treatment Market Forecast (2021-2025)
12.2.2 Europe Intracranial Atherosclerotic Disease Treatment Market Forecast (2021-2025)
12.2.3 Asia-Pacific Intracranial Atherosclerotic Disease Treatment Market Forecast (2021-2025)
12.2.4 South America Intracranial Atherosclerotic Disease Treatment Market Forecast (2021-2025)
12.2.5 Middle East & Africa Intracranial Atherosclerotic Disease Treatment Market Forecast (2021-2025)
12.3 Intracranial Atherosclerotic Disease Treatment Market Forecast by Type (2021-2025)
12.3.1 Global Intracranial Atherosclerotic Disease Treatment Sales Forecast by Type (2021-2025)
12.3.2 Global Intracranial Atherosclerotic Disease Treatment Market Share Forecast by Type (2021-2025)
12.4 Intracranial Atherosclerotic Disease Treatment Market Forecast by Application (2021-2025)
12.4.1 Global Intracranial Atherosclerotic Disease Treatment Sales Forecast by Application (2021-2025)
12.4.2 Global Intracranial Atherosclerotic Disease Treatment Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Intracranial Atherosclerotic Disease Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Intracranial Atherosclerotic Disease Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Intracranial Atherosclerotic Disease Treatment Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Intracranial Atherosclerotic Disease Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Stryker Basic Information, Manufacturing Base and Competitors
Table 9. Stryker Intracranial Atherosclerotic Disease Treatment Major Business
Table 10. Stryker Intracranial Atherosclerotic Disease Treatment Total Revenue (USD Million) (2018-2019)
Table 11. Stryker SWOT Analysis
Table 12. Stryker Intracranial Atherosclerotic Disease Treatment Product and Services
Table 13. Stryker Intracranial Atherosclerotic Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. MicroPort Basic Information, Manufacturing Base and Competitors
Table 15. MicroPort Intracranial Atherosclerotic Disease Treatment Major Business
Table 16. MicroPort Intracranial Atherosclerotic Disease Treatment Total Revenue (USD Million) (2018-2019)
Table 17. MicroPort SWOT Analysis
Table 18. MicroPort Intracranial Atherosclerotic Disease Treatment Product and Services
Table 19. MicroPort Intracranial Atherosclerotic Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Balt Basic Information, Manufacturing Base and Competitors
Table 21. Balt Intracranial Atherosclerotic Disease Treatment Major Business
Table 22. Balt Intracranial Atherosclerotic Disease Treatment Total Revenue (USD Million) (2018-2019)
Table 23. Balt SWOT Analysis
Table 24. Balt Intracranial Atherosclerotic Disease Treatment Product and Services
Table 25. Balt Intracranial Atherosclerotic Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. TERUMO Basic Information, Manufacturing Base and Competitors
Table 27. TERUMO Intracranial Atherosclerotic Disease Treatment Major Business
Table 28. TERUMO Intracranial Atherosclerotic Disease Treatment Total Revenue (USD Million) (2018-2019)
Table 29. TERUMO SWOT Analysis
Table 30. TERUMO Intracranial Atherosclerotic Disease Treatment Product and Services
Table 31. TERUMO Intracranial Atherosclerotic Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Acandis Basic Information, Manufacturing Base and Competitors
Table 33. Acandis Intracranial Atherosclerotic Disease Treatment Major Business
Table 34. Acandis Intracranial Atherosclerotic Disease Treatment Total Revenue (USD Million) (2018-2019)
Table 35. Acandis SWOT Analysis
Table 36. Acandis Intracranial Atherosclerotic Disease Treatment Product and Services
Table 37. Acandis Intracranial Atherosclerotic Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Global Intracranial Atherosclerotic Disease Treatment Sales by Manufacturer (2018-2019) (K Units)
Table 39. Global Intracranial Atherosclerotic Disease Treatment Revenue by Manufacturer (2018-2019) (USD Million)
Table 40. Global Intracranial Atherosclerotic Disease Treatment Sales by Regions (2015-2020) (K Units)
Table 41. Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Regions (2015-2020)
Table 42. Global Intracranial Atherosclerotic Disease Treatment Revenue by Regions (2015-2020) (USD Million)
Table 43. North America Intracranial Atherosclerotic Disease Treatment Sales by Countries (2015-2020) (K Units)
Table 44. North America Intracranial Atherosclerotic Disease Treatment Sales Market Share by Countries (2015-2020)
Table 45. North America Intracranial Atherosclerotic Disease Treatment Revenue by Countries (2015-2020) (USD Million)
Table 46. North America Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Countries (2015-2020)
Table 47. Europe Intracranial Atherosclerotic Disease Treatment Sales by Countries (2015-2020) (K Units)
Table 48. Europe Intracranial Atherosclerotic Disease Treatment Sales Market Share by Countries (2015-2020)
Table 49. Europe Intracranial Atherosclerotic Disease Treatment Revenue by Countries (2015-2020) (USD Million)
Table 50. Asia-Pacific Intracranial Atherosclerotic Disease Treatment Sales by Regions (2015-2020) (K Units)
Table 51. Asia-Pacific Intracranial Atherosclerotic Disease Treatment Sales Market Share by Regions (2015-2020)
Table 52. Asia-Pacific Intracranial Atherosclerotic Disease Treatment Revenue by Regions (2015-2020) (USD Million)
Table 53. South America Intracranial Atherosclerotic Disease Treatment Sales by Countries (2015-2020) (K Units)
Table 54. South America Intracranial Atherosclerotic Disease Treatment Sales Market Share by Countries (2015-2020)
Table 55. South America Intracranial Atherosclerotic Disease Treatment Revenue by Countries (2015-2020) (USD Million)
Table 56. South America Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Intracranial Atherosclerotic Disease Treatment Sales by Countries (2015-2020) (K Units)
Table 58. Middle East & Africa Intracranial Atherosclerotic Disease Treatment Sales Market Share by Countries (2015-2020)
Table 59. Middle East & Africa Intracranial Atherosclerotic Disease Treatment Revenue by Countries (2015-2020) (USD Million)
Table 60. Middle East & Africa Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Countries (2015-2020)
Table 61. Global Intracranial Atherosclerotic Disease Treatment Sales by Type (2015-2020) (K Units)
Table 62. Global Intracranial Atherosclerotic Disease Treatment Sales Share by Type (2015-2020)
Table 63. Global Intracranial Atherosclerotic Disease Treatment Revenue by Type (2015-2020) (USD Million)
Table 64. Global Intracranial Atherosclerotic Disease Treatment Revenue Share by Type (2015-2020)
Table 65. Global Intracranial Atherosclerotic Disease Treatment Sales by Application (2015-2020) (K Units)
Table 66. Global Intracranial Atherosclerotic Disease Treatment Sales Share by Application (2015-2020)
Table 67. Global Intracranial Atherosclerotic Disease Treatment Sales Forecast by Regions (2021-2025) (K Units)
Table 68. Global Intracranial Atherosclerotic Disease Treatment Market Share Forecast by Regions (2021-2025)
Table 69. Global Intracranial Atherosclerotic Disease Treatment Sales Forecast by Type (2021-2025) (K Units)
Table 70. Global Intracranial Atherosclerotic Disease Treatment Market Share Forecast by Type (2021-2025)
Table 71. Global Intracranial Atherosclerotic Disease Treatment Sales Forecast by Application (2021-2025)
Table 72. Global Intracranial Atherosclerotic Disease Treatment Market Share Forecast by Application (2021-2025)
Table 73. Direct Channel Pros & Cons
Table 74. Indirect Channel Pros & Cons
Table 75. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Intracranial Atherosclerotic Disease Treatment Picture
Figure 2. Global Sales Market Share of Intracranial Atherosclerotic Disease Treatment by Type in 2019
Figure 3. Stent Picture
Figure 4. PTA Balloon Picture
Figure 5. Intracranial Atherosclerotic Disease Treatment Sales Market Share by Application in 2019
Figure 6. Hospital Picture
Figure 7. Clinic Picture
Figure 8. Other Picture
Figure 9. Global Intracranial Atherosclerotic Disease Treatment Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Intracranial Atherosclerotic Disease Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Intracranial Atherosclerotic Disease Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Intracranial Atherosclerotic Disease Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Intracranial Atherosclerotic Disease Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Intracranial Atherosclerotic Disease Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Intracranial Atherosclerotic Disease Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Intracranial Atherosclerotic Disease Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Intracranial Atherosclerotic Disease Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Intracranial Atherosclerotic Disease Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Intracranial Atherosclerotic Disease Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Intracranial Atherosclerotic Disease Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Intracranial Atherosclerotic Disease Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Intracranial Atherosclerotic Disease Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Intracranial Atherosclerotic Disease Treatment Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Intracranial Atherosclerotic Disease Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Intracranial Atherosclerotic Disease Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Intracranial Atherosclerotic Disease Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Intracranial Atherosclerotic Disease Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Intracranial Atherosclerotic Disease Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Manufacturer in 2019
Figure 30. Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Intracranial Atherosclerotic Disease Treatment Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Intracranial Atherosclerotic Disease Treatment Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Intracranial Atherosclerotic Disease Treatment Sales and Growth Rate (2015-2020) (K Units)
Figure 35. Global Intracranial Atherosclerotic Disease Treatment Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Regions (2015-2020)
Figure 37. Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Regions in 2018
Figure 38. North America Intracranial Atherosclerotic Disease Treatment Sales and Growth Rate (2015-2020)
Figure 39. Europe Intracranial Atherosclerotic Disease Treatment Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Intracranial Atherosclerotic Disease Treatment Sales and Growth Rate (2015-2020)
Figure 41. South America Intracranial Atherosclerotic Disease Treatment Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Intracranial Atherosclerotic Disease Treatment Sales and Growth Rate (2015-2020)
Figure 43. North America Intracranial Atherosclerotic Disease Treatment Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Intracranial Atherosclerotic Disease Treatment Sales Market Share by Countries (2015-2020)
Figure 45. North America Intracranial Atherosclerotic Disease Treatment Sales Market Share by Countries in 2018
Figure 46. North America Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Countries in 2018
Figure 48. United States Intracranial Atherosclerotic Disease Treatment Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Canada Intracranial Atherosclerotic Disease Treatment Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Mexico Intracranial Atherosclerotic Disease Treatment Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Europe Intracranial Atherosclerotic Disease Treatment Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Countries in 2019
Figure 54. Germany Intracranial Atherosclerotic Disease Treatment Sales and Growth Rate (2015-2020) (K Units)
Figure 55. UK Intracranial Atherosclerotic Disease Treatment Sales and Growth Rate (2015-2020) (K Units)
Figure 56. France Intracranial Atherosclerotic Disease Treatment Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Russia Intracranial Atherosclerotic Disease Treatment Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Italy Intracranial Atherosclerotic Disease Treatment Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Asia-Pacific Intracranial Atherosclerotic Disease Treatment Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Intracranial Atherosclerotic Disease Treatment Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Regions 2019
Figure 62. China Intracranial Atherosclerotic Disease Treatment Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Japan Intracranial Atherosclerotic Disease Treatment Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Korea Intracranial Atherosclerotic Disease Treatment Sales and Growth Rate (2015-2020) (K Units)
Figure 65. India Intracranial Atherosclerotic Disease Treatment Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Southeast Asia Intracranial Atherosclerotic Disease Treatment Sales and Growth Rate (2015-2020) (K Units)
Figure 67. South America Intracranial Atherosclerotic Disease Treatment Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Intracranial Atherosclerotic Disease Treatment Sales Market Share by Countries in 2019
Figure 69. South America Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Countries in 2019
Figure 70. Brazil Intracranial Atherosclerotic Disease Treatment Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Argentina Intracranial Atherosclerotic Disease Treatment Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Middle East and Africa Intracranial Atherosclerotic Disease Treatment Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Intracranial Atherosclerotic Disease Treatment Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Intracranial Atherosclerotic Disease Treatment Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Egypt Intracranial Atherosclerotic Disease Treatment Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Turkey Intracranial Atherosclerotic Disease Treatment Sales and Growth Rate (2015-2020) (K Units)
Figure 79. South Africa Intracranial Atherosclerotic Disease Treatment Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Global Intracranial Atherosclerotic Disease Treatment Sales and Growth Rate (2021-2025) (K Units)
Figure 81. Global Intracranial Atherosclerotic Disease Treatment Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Intracranial Atherosclerotic Disease Treatment Market Forecast (2021-2025) (K Units)
Figure 83. Europe Sales Intracranial Atherosclerotic Disease Treatment Market Forecast (2021-2025) (K Units)
Figure 84. Asia-Pacific Sales Intracranial Atherosclerotic Disease Treatment Market Forecast (2021-2025) (K Units)
Figure 85. South America Sales Intracranial Atherosclerotic Disease Treatment Market Forecast (2021-2025) (K Units)
Figure 86. Middle East & Africa Sales Intracranial Atherosclerotic Disease Treatment Market Forecast (2021-2025) (K Units)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
頭蓋内出血診断・治療の世界市場（～2026年） Bleeding or haemorrhages loss of blood from the circulatory system which may be internal or external due to variety of conditions such as trauma, tissue damage due to surgery, accidents, cuts etc. Generally loss of 10–15% of the total blood volume does not cause serious mental problems and can be to…- 特発性頭蓋内圧亢進症治療の世界市場（～2026年） Idiopathic intracranial hypertension is characterized by a buildup of the cerebrospinal fluid causing increase in the blood volume in vessels surrounding the brain and increase in brain swelling. The increase in salt intake causes water retention in the body together with fat adding on to the calori…
- 頭蓋内ステントの世界市場（～2026年） Market Analysis and Insights: Global Intracranial Stent Market The global Intracranial Stent market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Intracranial Stent Scope and Market Size Intracranial Stent market is segment…
- クラッベ病治療の世界市場（～2026年） Krabbe disease (KD) (also known as globoid cell leukodystrophy or galactosylceramide lipidosis) is a rare and often fatal lysosomal storage disease that results in progressive damage to the nervous system. KD involves dysfunctional metabolism of sphingolipids and is inherited in an autosomal recessi…
- 頭蓋内シャント装置の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Intracranial Shunt Device market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Intracranial Shunt …